ArticleJMIR research protocols2021

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study.

Fatima Jamali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.